Test Image Caption

test
Novartis provides information and resources for healthcare

 

Collaboration between the pharmaceutical industry and Healthcare Professionals (HCPs) or Healthcare Organizations (HCOs) or Patient Organizations (PO) benefit patients. It is a relationship that has delivered numerous break-through medicines and changed the way many diseases impact patients’ lives. Our work together includes a range of activities from clinical research to sharing best clinical practice. As an industry we make payments or ‘transfers of value’ to Healthcare Professionals and Organizations to compensate them for the time spent working with Novartis.

Bringing greater transparency to this already well-regulated relationship builds understanding of this collaboration and addresses public concerns about interactions between the medical community and the pharmaceutical industry. We believe that openly communicating payments helps foster trust with patients, Healthcare Professionals, government officials and the public, and supports our overall commitment to data transparency and high ethical business standards. Novartis has long been dedicated to improving clinical trial data transparency and discloses relationships with patient organizations.